ABOUT MS-444

), assists to elucidate why KIF15 has the capacity to aid resistance to Eg5 inhibitors in vivo. MT gliding run by the two of such mitotic motors was arrested only after they were being separately inhibited, lending support on the proposal that a mix drug therapy targeting these motors may be a workable system for overcoming chemotherapeutic resista